Startuprad.io - The Authority on German Startup‪s‬ On the New York City Podcast Network

The Journey Of Mainz BioMed: From Start-up To A NASDAQ Listing

Play This Episode

11 Votes

Executive Summary In this episode of Startuprad io host Joe Menninger interviews Guido Baechler CEO of Mainz BioMed about the company s innovative at-home colorectal cancer test kit designed to improve early detection and survival rates Baechler discusses the challenges and opportunities of operating in the biotech sector including navigating U S and European regulations and fostering a culture of innovation within a NASDAQ-listed company He shares insights from his background at Roche Diagnostics and emphasizes the importance of an open trustful company culture The episode also touches on Mainz BioMed s expansion plans and the significance of colorectal cancer awareness Interested in Working with us Have a look here https www passionfroot me startupradio Introduction Welcome to another exciting episode of Startuprad io where we bring you the stories of innovation and entrepreneurship directly from the heart of the startup ecosystem I m your host J rn Joe Menninger and today we re diving into a topic of crucial importance the fight against colorectal cancer In this March 2024 awareness month episode we re honored to welcome Guido Baechler CEO of Mainz BioMed a trailblazing German biotech company listed on Nasdaq With a fascinating journey from Roche Diagnostics to the dynamic world of startups Guido brings a wealth of knowledge on PCR technology cutting-edge diagnostic tools and the importance of early cancer detection As we explore Mainz BioMed s innovative approach to cancer screening including their noninvasive at-home test that s changing the game in colorectal cancer prevention Guido shares the company s mission its challenges with market trends and diverse regulatory environments and how they maintain a culture of innovation amidst stringent healthcare regulations Join us as we delve into the importance of self-care the impact of lifestyle on cancer risk and why Guido left the security of a large firm for the risk-rich terrain of startups Through an inspirational tale of a test that transformed one mother s life we ll see the real-world impact of Mainz BioMed s commitment to early detection So whether you re a budding entrepreneur a healthcare professional or someone passionate about making a difference this is one episode you can t afford to miss Don t Miss An Episode Follow us on Telegram and get alters when we publish a new episode https t me startupradiochannel Not enough time Join our monthly Newsletter on Slack https startupradio substack com The Interviewer Follow him on LinkedIn http www linkedin com comm mynetwork discovery-see-all usecase PEOPLE FOLLOWS amp followMember joernmenninger Follow him on Twitter https twitter com joemenninger Find all blog posts with all the links on our blog https medium com startuprad-io the-journey-of-mainz-biomed-from-start-up-to-a-nasdaq-listing-4843c0b06412 FeedbackPlease take this opportunity and share your feedback with us We would love to hear from YOU https forms gle mLV6mVKwGwKuut8BA Startuprad io – All Rights Reserved Click here to visit this podcast episode

Listen to our podcast on podcasting success!